Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-26 @ 3:30 AM
Study NCT ID:
NCT06163820
Status:
RECRUITING
Last Update Posted:
2025-05-13
First Post:
2023-10-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Sponsor:
Melanoma and Skin Cancer Trials Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-01-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-17
First Submit QC Date:
None
Study First Post Date:
2023-12-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-08
Last Update Post Date:
2025-05-13
Last Update Post Date Type:
ACTUAL